Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy: a Randomized, Double-blinded, Placebo-Controlled Trial
Clinical trial NCT07604311 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07604311
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-12-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.